However, upon malignant transformation which is characterised by ECM degradation and down‐regulation of ECM components, the AnxA2‐mediated repressive functions in the context of type I collagen expression are enhanced, contributing to decreased type I collagen synthesis in favour of cancer development and progression. Here, ANXA2 is linked to cancer.